Advertisement
Rapid Communication| Volume 157, 102029, June 2020

Download started.

Ok

ISSFAL Official Statement Number 6: The importance of measuring blood omega-3 long chain polyunsaturated fatty acid levels in research

  • Renate H.M. de Groot
    Affiliations
    Faculty of Psychology and Educational Sciences, Welten Institute, Research Centre for Learning, Teaching and Technology, Open University of the Netherlands, Valkenburgerweg 177, 6419AT Heerlen, the Netherlands
    Search for articles by this author
  • Barbara J. Meyer
    Correspondence
    Corresponding author.
    Affiliations
    School of Medicine, Lipid Research Centre, Molecular Horizons, University of Wollongong and Illawarra Health & Medical Research Institute, Northfields Avenue, Wollongong, NSW 2522, Australia
    Search for articles by this author
Published:November 06, 2019DOI:https://doi.org/10.1016/j.plefa.2019.102029

      Highlights

      • The ISSFAL Official Statement Number 6 has been approved for publication by the ISSFAL Board of Directors on 9 October 2019.
      • There are many factors associated with n-3 LCPUFA levels and these have been described in a systematic literature review [1].
      • This statement highlights the importance of measuring blood omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) levels in research.

      Abstract

      A statement on measuring blood omega-3 long chain polyunsaturated fatty acid levels was developed and edited based on input from ISSFAL members and accepted by vote of the ISSFAL Board of Directors.
      Summary of Statement: Omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) levels at baseline and post-intervention should be assessed and reported in future research to evaluate the efficacy of n-3 LCPUFA supplementation: b
      ecause; 1. there are numerous factors that affect n-3 LCPUFA levels in humans as described in the systematic literature review [
      • de Groot R.H.M.
      • Emmett R.
      • Meyer B.J.
      Non-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature review.
      ]; 2. assessing intake of n-3 LCPUFA from the diet and/or supplements is not sufficient to accurately determine n-3 LCPUFA levels in humans; 3. some studies do not provide sufficient doses of n-3 LCPUFA to produce a significant impact on bloodstream/organ content and there is substantial variability in the uptake of n-3 LPCUFA into tissues between individuals. In secondary analyses, clinical trials should consider the influence of fatty acid status (baseline, endpoint and change from baseline to endpoint) on the outcome variables.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • de Groot R.H.M.
        • Emmett R.
        • Meyer B.J.
        Non-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature review.
        Br. J. Nutr. 2019; 121: 793-808
        • Calder P.C.
        • Yaqoob P.
        Omega-3 polyunsaturated fatty acids and human health outcomes.
        BioFactors. 2009; 35: 266-272
        • Meyer B.J.
        • Onyiaodike C.C.
        • Brown E.A.
        • Jordan F.
        • Murray H.
        • Nibbs R.J.
        • Sattar N.
        • Lyall H.
        • Nelson S.M.
        • Freeman D.J.
        Maternal plasma DHA levels increase prior to 29 days Post-LH surge in women undergoing frozen embryo transfer: a prospective, observational study of human pregnancy.
        J. Clin. Endocrinol. Metab. 2016; 101: 1745-1753
        • Makrides M.
        • Gibson R.A.
        Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation.
        Am. J. Clin. Nutr. 2000; 71: 307S-311S
        • GISSI Prevezione Investigators
        Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
        Lancet. 1999; 354: 447-455
        • Yokoyama M.
        • Origasa H.
        • Matsuzaki M.
        • Matsuzawa Y.
        • Saito Y.
        • Ishikawa Y.
        • Oikawa S.
        • Sasaki J.
        • Hishida H.
        • Itakura H.
        • Kita T.
        • Kitabatake A.
        • Nakaya N.
        • Sakata T.
        • Shimada K.
        • Shirato K.
        Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
        Lancet. 2007; 369: 1090-1098
        • Sinn N.
        • Milte C.
        • Howe P.R.
        Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.
        Nutrients. 2010; 2: 128-170
        • Parletta N.
        • Milte C.M.
        • Meyer B.J.
        Nutritional modulation of cognitive function and mental health.
        J. Nutr. Biochem. 2013; 24: 725-743
        • Lands W.E.M.
        Biochemistry and physiology of n-3 fatty acids.
        FASEB J. 1992; 6: 2530-2536
        • Meyer B.J.
        Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health?.
        Prostraglandins Leukot. Essent. Fatty Acids. 2011; 85: 275-280
        • Harris W.S.
        • Von Schacky C.
        The Omega-3 Index: a new risk factor for death from coronary heart disease?.
        Prev. Med. 2004; 39: 212-220
        • Swierk M.
        • Williams P.G.
        • Wilcox J.
        • Russell K.G.
        • Meyer B.J.
        Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake.
        Nutrition. 2011; 27: 641-646
        • Ingram M.A.
        • Stonehouse W.
        • Russell K.G.
        • Meyer B.J.
        • Kruger R.
        The New Zealand PUFA semiquantitative food frequency questionnaire is a valid and reliable tool to assess PUFA intakes in healthy New Zealand adults.
        J. Nutr. 2012; 142: 1968-1974
        • Meyer B.J.
        • Swierk M.
        • Russell K.G.
        Assessing long-chain omega-3 polyunsaturated fatty acids: a tailored food-frequency questionnaire is better.
        Nutrition. 2013; 29: 491-496
        • Bingham S.A.
        Limitations of the various methods for collecting dietary intake data.
        Ann. Nutr. Metab. 1991; 35: 117-127
        • Lohner S.
        • Fekete K.
        • Marosvölgyi T.
        • Decsi T.
        Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications.
        Ann. Nutr. Metab. 2013; 62: 98-112
        • Harris W.S.
        • Pottala J.V.
        • Varvel S.A.
        • Borowski J.J.
        • Ward J.N.
        • McConnell J.P.
        Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.
        Prostraglandins Leukot. Essent. Fatty Acids. 2013; 88: 257-263
        • Al-Hilal M.
        • Alsaleh A.
        • Maniou Z.
        • Lewis F.J.
        • Hall W.L.
        • Sanders T.A.
        • O'Dell S.D.
        • team M.s.
        Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement.
        J. Lipid Res. 2013; 54: 542-551
        • Mathias R.A.
        • Vergara C.
        • Gao L.
        • Rafaels N.
        • Hand T.
        • Campbell M.
        • Bickel C.
        • Ivester P.
        • Sergeant S.
        • Barnes K.C.
        • Chilton F.H.
        FADS genetic variants and omega-6 polyunsaturated fatty acid metabolism in a homogeneous island population.
        J. Lipid Res. 2010; 51: 2766-2774
        • Gillingham L.G.
        • Harding S.V.
        • Rideout T.C.
        • Yurkova N.
        • Cunnane S.C.
        • Eck P.K.
        • Jones P.J.
        Dietary oils and FADS1-FADS2 genetic variants modulate [13C]alpha-linolenic acid metabolism and plasma fatty acid composition.
        Am. J. Clin. Nutr. 2013; 97: 195-207
        • Schaeffer L.
        • Gohlke H.
        • Muller M.
        • Heid I.M.
        • Palmer L.J.
        • Kompauer I.
        • Demmelmair H.
        • Illig T.
        • Koletzko B.
        • Heinrich J.
        Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids.
        Hum. Mol. Genet. 2006; 15: 1745-1756
        • Tanaka T.
        • Shen J.
        • Abecasis G.R.
        • Kisialiou A.
        • Ordovas J.M.
        • Guralnik J.M.
        • Singleton A.
        • Bandinelli S.
        • Cherubini A.
        • Arnett D.
        • Tsai M.Y.
        • Ferrucci L.
        Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study.
        PLoS Genet. 2009; 5e1000338
        • Baylin A.
        • Ruiz-Naraez E.
        • Kraft P.
        • Campos H.
        Alpha-linolenic acid, delta 6 desaturase gene polymorphism, and the risk of myocardial infarction.
        Am. J. Clin. Nutr. 2007; 85: 554-560
        • Alsaleh A.
        • Maniou Z.
        • Lewis F.J.
        • Hall W.L.
        • Sanders T.A.
        • O'Dell S.D.
        ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement.
        Genes Nutr. 2014; 9: 362
        • Harris W.S.
        • Pottala J.V.
        • Lacey S.M.
        • Vasan R.S.
        • Larson M.G.
        • Robins S.J.
        Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.
        Atherosclerosis. 2012; 225: 425-431
        • Walker C.G.
        • Browning L.M.
        • Mander A.P.
        • Madden J.
        • West A.L.
        • Calder P.C.
        • Jebb S.A.
        Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans.
        Br. J. Nutr. 2014; 111: 679-689
        • Fortier M.
        • Tremblay-Mercier J.
        • Plourde M.
        • Chouinard-Watkins R.
        • Vandal M.
        • Pifferi F.
        • Freemantle E.
        • Cunnane S.C.
        Higher plasma n-3 fatty acid status in the moderately healthy elderly in southern Quebec: higher fish intake or aging-related change in n-3 fatty acid metabolism?.
        Prostraglandins Leukot. Essent. Fatty Acids. 2010; 82: 277-280
        • Rees D.
        • Miles E.
        • Banerjee T.
        • Wells S.
        • Roynette C.
        • Wahle K.
        • Calder P.
        Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men.
        Am. J. Clin. Nutr. 2006; 83: 331-342
        • Vandal M.
        • Freemantle E.
        • Tremblay-Mercier J.
        • Plourde M.
        • Fortier M.
        • Bruneau J.
        • Gagnon J.
        • Begin M.
        • Cunnane S.C.
        Plasma omega-3 fatty acid response to a fish oil supplement in the healthy elderly.
        Lipids. 2008; 43: 1085-1089
        • Plourde M.
        • Chouinard-Watkins R.
        • Vandal M.
        • Zhang Y.
        • Lawrence P.
        • Brenna J.T.
        • Cunnane S.C.
        Plasma incorporation, apparent retroconversion and [beta]-oxidation of 13 C-docosahexaenoic acid in the elderly.
        J. Nutr. Metab. 2011; 8: 5
        • Hennebelle M.
        • Courchesne-Loyer A.
        • St-Pierre V.
        • Vandenberghe C.
        • Castellano C.-A.
        • Fortier M.
        • Tessier D.
        • Cunnane S.C.
        Preliminary evaluation of a differential effect of an [alpha]-linolenate-rich supplement on ketogenesis and plasma [omega]-3 fatty acids in young and older adults.
        Nutrition. 2016; 32: 1211-1216
        • Bjerve K.S.
        • Fougner K.J.
        • Midthjell K.
        • Bønaa K.
        n-3 fatty acids in old age.
        J. Intern. Med. 1989; 731: 191-196
        • Kuriki K.
        • Nagaya T.
        • Imaeda N.
        • Tokudome Y.
        • Fujiwara N.
        • Sato J.
        • Ikeda M.
        • Maki S.
        • Tokudome S.
        • et al.
        Discrepancies in dietary intakes and plasma concentrations of fatty acids according to age among Japanese female dietitians.
        Eur. J. Clin. Nutr. 2002; 56: 524-531
        • Ogura T.
        • Takada H.
        • Okuno M.
        • Kitade H.
        • Matsuura T.
        • Kwon M.
        • Arita S.
        • Hamazaki K.
        • Itomura M.
        • Hamazaki T.
        Fatty acid composition of plasma, erythrocytes and adipose: their correlations and effects of age and sex.
        Lipids. 2010; 45: 137-144
        • Otsuka R.
        • Kato Y.
        • Imai T.
        • Ando F.
        • Shimokata H.
        Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79.
        Lipids. 2013; 48: 719-727
        • Sands S.A.
        • Reid K.J.
        • Windsor S.L.
        • Harris W.S.
        The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes.
        Lipids. 2005; 40: 343-347
        • de Groot R.H.
        • van Boxtel M.P.
        • Schiepers O.J.
        • Hornstra G.
        • Jolles J.
        Age dependence of plasma phospholipid fatty acid levels: potential role of linoleic acid in the age-associated increase in docosahexaenoic acid and eicosapentaenoic acid concentrations.
        Br. J. Nutr. 2009; 102: 1058-1064
        • Bolton-Smith C
        • Woodward M
        • Tavendale R
        Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet.
        Eur. J. Clin. Nutr. 1997; 51: 619-624
        • Block R.C.
        • Harris W.S.
        • Pottala J.V.
        Determinants of blood cell omega-3 fatty acid content.
        Open Biomark. J. 2008; 1: 1-6
      1. T. Kawabata, S. Hirota, T. Hirayama, N. Adachi, C. Hagiwara, N. Iwama, K. Kamachi, E. Araki, H. Kawashima, Y. Kiso, Age-related changes of dietary intake and blood eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid levels in Japanese men and women, Prostaglandins Leukot. Essent. Fatty Acids, 84 (2011) 131–137.

        • Crowe F.L.
        • Skeaff C.M.
        • Green T.J.
        • Gray A.R.
        Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults.
        Br. J. Nutr. 2008; 99: 168-174
        • Saga L.C.
        • Liland K.H.
        • Leistad R.B.
        • Reimers A.
        • Rukke E.O.
        Relating fatty acid composition in human fingertip blood to age, gender, nationality and n-3 supplementation in the Scandinavian population.
        Int. J. Food Sci. Nutr. 2012; 63: 790-795
        • Dewailly E.
        • Blanchet C.
        • Lemieux S.
        • Gingras S.
        • Holub B.J.
        Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree.
        Am. J. Clin. Nutr. 2002; 76: 85-92
        • Dewailly E.
        • Blanchet C.
        • Gingras S.
        • Lemieux S.
        • Sauve L.
        • Bergeron J.
        • Holub B.J.
        Relations between n-3 fatty acid status and cardiovascular disease risk factors among quebecers.
        Am. J. Clin. Nutr. 2001; 74: 603-611
        • Dewailly E.
        • Blanchet C.
        • Lemieux S.
        • Sauve L.
        • Gingras S.
        • Ayotte P.
        • Holub B.J.
        n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik.
        Am. J. Clin. Nutr. 2001; 74: 464-473
        • Itomura M.
        • Fujioka S.
        • Hamazaki K.
        • Kobayashi K.
        • Nagasawa T.
        • Sawazak S.
        • Kirihara Y.
        • Hamazaki T.
        Factors influencing EPA plus DHA levels in red blood cells in Japan.
        In Vivo. 2008; 22: 131-135
        • Tavendale R.
        • Lee A.J.
        • Smith W.C.
        • Tunstall-Pedoe H.
        Adipose tissue fatty acids in Scottish men and women: results from the Scottish Heart Health Study.
        Atherosclerosis. 1992; 94: 161-169
        • Cazzola R.
        • Rondanelli M.
        • Russo-Volpe S.
        • Ferrari E.
        • Cestaro B.
        Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes.
        J. Lipid Res. 2004; 45: 1846-1851
        • Micallef M.
        • Munro I.
        • Phang M.
        • Garg M.
        Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity.
        Br. J. Nutr. 2009; 102: 1370-1374
        • Howe P.R.
        • Buckley J.D.
        • Murphy K.J.
        • Pettman T.
        • Milte C.
        • Coates A.M.
        Relationship between erythrocyte omega-3 content and obesity is gender dependent.
        Nutrients. 2014; 6: 1850-1860
        • Sala-Vila A.
        • Harris W.S.
        • Cofán M.
        • Pérez-Heras A.M.
        • Pintó X.
        • Lamuela-Raventós R.M.
        • Covas M.-I.
        • Estruch R.
        • Ros E.
        Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD.
        Br. J. Nutr. 2011; 106: 425-431
        • Kuriki K.
        • Nagaya T.
        • Tokudome Y.
        • Imaeda N.
        • Fujiwara N.
        • Sato J.
        • Goto T.
        • Ikeda M.
        • Maki S.
        • Tajima S.
        • Tokudome S.
        • et al.
        Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study.
        J. Nutr. 2003; 133: 3643-3650
        • Makhoul Z.
        • Kristal A.R.
        • Gulati R.
        • Luick B.
        • Bersamin A.
        • O'Brien D.
        • Hopkins S.E.
        • Stephensen C.B.
        • Stanhope K.L.
        • Havel P.J.
        • Boyer B.
        Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids.
        Eur. J. Nutr. 2011; 65: 808-817
        • Sumikawa K.
        • Mu Z.
        • Inoue T.
        • Okochi T.
        • Yoshida T.
        • Adachi K.
        Changes in erythrocyte membrane phospholipid composition induced by physical training and physical exercise.
        Eur. J. Appl. Physiol. 1993; 67: 132-137
        • Andersson A
        • Sjodin A
        • Hedman A
        • Olsson R
        • Vessby B
        Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men.
        Am. J. Physiol. Endocrinol. Metab. 2000; 279: E744-E751
        • Kamada T.
        • Tokuda S.
        • Aozaki S.
        • Otsuji S.
        Higher levels of erythrocyte membrane fluidity in sprinters and long-distance runners.
        J. Appl. Physiol. 1993; 74: 354-358
        • Arsic A.
        • Vucic V.
        • Tepsic J.
        • Mazic S.
        • Djelic M.
        • Glibetic M.
        Altered plasma and erythrocyte phospholipid fatty acid profile in elite female water polo and football players.
        Appl. Physiol. Nutr. Metab. 2012; 37: 40-47
        • Tepsic J.
        • Vucic V.
        • Arsic A.
        • Blazencic-Mladenovic V.
        • Mazic S.
        • Glibetic M.
        Plasma and erythrocyte phospholipid fatty acid profile in professional basketball and football players.
        Eur. J. Appl. Physiol. 2009; 107: 359-365
        • Theret N.
        • Bard J.M.
        • Nuttens M.C.
        • Lecerf J.M.
        • Delbart C.
        • Romon M.
        • Salomez J.L.
        • Fruchart J.C.
        The relationship between the phospholipid fatty acid composition of red blood cells, plasma lipids, and apolipoproteins.
        Metabolism. 1993; 42: 562-568
        • Alling C.
        • Gustavsson L.
        • Kristensson-Aas A.
        • Wallerstedt S.
        Changes in fatty acid composition of major glycerophospholipids in erythrocyte membranes from chronic alcoholics during withdrawal.
        Scan. J. Clin. Lab. Investig. 1984; 44: 283-289
        • de Lorgeril M.
        • Salen P.
        • Martin J.-L.
        • Boucher F.
        • de Leiris J.
        Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: a fish-like effect of moderate wine drinking.
        Am. Heart J. 2008; 155: 175-181
        • di Giuseppe R.
        • de Lorgeril M.
        • Salen P.
        • Laporte F.
        • Di Castelnuovo A.
        • Krogh V.
        • Siani A.
        • Arnout J.
        • Cappuccio F.P.
        • van Dongen M.
        • Donati M.B.
        • de Gaetano G.
        • Iacoviello L.
        • I.P. European Collaborative Group of the
        Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations.
        Am. J. Clin. Nutr. 2009; 89: 354-362
        • Perret B.
        • Ruidavets J.B.
        • Vieu C.
        • Jaspard B.
        • Cambou J.P.
        • Terce F.
        • Collet X.
        Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate.
        Alcohol Clin. Exp. Res. 2002; 26: 1134-1140
        • Simonetti P.
        • Brusamolino A.
        • Pellegrini N.
        • Viana P.
        • Clemente G.
        • Roggi C.
        • Cestaro B.
        Evaluation of the effect of alcohol consumption on erythrocyte lipids and vitamins in a healthy population.
        Alcohol Clin. Exp. Res. 1995; 19: 517-522
        • Simon J.A.
        • Fong J.
        • Bernert J.
        • Browner W.
        Relation of smoking and alcohol consumption to serum fatty acids.
        Am. J. Epidemiol. 1996; 144: 325-334
        • Leng G.C.
        • Smith F.B.
        • Fowkes F.G.R.
        • Horrobin D.F.
        • Ells K.
        • Morsefisher N.
        • Lowe G.D.O.
        Relationship between plasma essential fatty-acids and smoking, serum-lipids, blood-pressure and hemostatic and rheological factors.
        Prostraglandins Leukot. Essent. Fatty Acids. 1994; 51: 101-108
        • Hibbeln J.R.
        • Makino K.K.
        • Martin C.E.
        • Dickerson F.
        • Boronow J.
        • Fenton W.S.
        Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder.
        Biol. Psychol. 2003; 53: 431-441
        • Ulven S.M.
        • Holven K.B.
        Comparison of bioavailability of krill oil versus fish oil and health effect.
        Vasc. Health Risk Manag. 2015; 11: 511-524
        • Yurko-Mauro K.
        • Kralovec J.
        • Bailey-Hall E.
        • Smeberg V.
        • Stark J.G.
        • Salem Jr., N.
        Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
        Lipids Health Dis. 2015; 14: 99
        • Schuchardt J.P.
        • Hahn A.
        Bioavailability of long-chain omega-3 fatty acids.
        Prostraglandins Leukot. Essent. Fatty Acids. 2013; 89: 1-8
        • West A.L.
        • Burdge G.C.
        • Calder P.C.
        Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial.
        Br. J. Nutr. 2016; 116: 788-797
        • Baker E.J.
        • Miles E.A.
        • Burdge G.C.
        • Yaqoob P.
        • Calder P.C.
        Metabolism and functional effects of plant-derived omega-3 fatty acids in humans.
        Prog. Lipid Res. 2016; 64: 30-56
        • Brenna J.T.
        • Plourde M.
        • Stark K.D.
        • Jones P.J.
        • Lin Y.H.
        Best practices for the design, laboratory analysis, and reporting of trials involving fatty acids..
        Am J Clin Nutr. 2018; 108: 211-227
        • Browning L.M.
        • Walker C.G.
        • Mander A.P.
        • West A.L.
        • Madden J.
        • Gambell J.M.
        • Young S.
        • Wang L.
        • Jebb S.A.
        • Calder P.C.
        Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish..
        Am J Clin Nutr. 2012; 96: 748-758
        • Stark K.D.
        • Aristizabal Henao J.J.
        • Metherel A.H.
        • Pilote L.
        Translating plasma and whole blood fatty acid compositional data into the sum of eicosapentaenoic and docosahexaenoic acid in erythrocytes.
        Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2016; 104: 1-10